These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 21701528
1. Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy. Kitazawa Y, Smith P, Sasaki N, Kotake S, Bae K, Iwamoto Y. Eye (Lond); 2011 Sep; 25(9):1161-9. PubMed ID: 21701528 [Abstract] [Full Text] [Related]
2. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D. Eur J Ophthalmol; 2007 Sep; 17(2):183-90. PubMed ID: 17415690 [Abstract] [Full Text] [Related]
6. Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension. Peace JH, Ahlberg P, Wagner M, Lim JM, Wirta D, Branch JD. Am J Ophthalmol; 2015 Aug; 160(2):266-274.e1. PubMed ID: 25935098 [Abstract] [Full Text] [Related]
7. Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial. DuBiner HB, Hubatsch DA. BMC Ophthalmol; 2014 Nov 28; 14():151. PubMed ID: 25432143 [Abstract] [Full Text] [Related]
11. Duration of IOP reduction with travoprost BAK-free solution. Gross RL, Peace JH, Smith SE, Walters TR, Dubiner HB, Weiss MJ, Ochsner KI. J Glaucoma; 2008 Nov 28; 17(3):217-22. PubMed ID: 18414108 [Abstract] [Full Text] [Related]
12. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension. Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM. Am J Ophthalmol; 2005 Aug 28; 140(2):242-50. PubMed ID: 16086946 [Abstract] [Full Text] [Related]
13. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA, Travoprost Study Group. Am J Ophthalmol; 2001 Oct 28; 132(4):472-84. PubMed ID: 11589866 [Abstract] [Full Text] [Related]
18. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost. Aihara M, Otani S, Kozaki J, Unoki K, Takeuchi M, Minami K, Miyata K. J Glaucoma; 2012 Jan 28; 21(1):60-4. PubMed ID: 21278589 [Abstract] [Full Text] [Related]
20. Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy. Lewis RA, Katz GJ, Weiss MJ, Landry TA, Dickerson JE, James JE, Hua SY, Sullivan EK, Montgomery DB, Wells DT, Bergamini MV, Travoprost BAC-free Study Group. J Glaucoma; 2007 Jan 28; 16(1):98-103. PubMed ID: 17224758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]